July 21, 2008 – Toshiba America Medical Systems said today that four live cases using the Infinix CF-i/BP will be showcased at the Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS) held in Las Vegas July 20-23.
Two hospitals that recently acquired the Infinix CF-i/BP will be performing live cases over the course of the symposium – Rush University Medical Center and the Children’s Healthcare of Atlanta Sibley Heart Center.
On July 21, Ziyad M. Hijazi, M.D., director of the Rush Center for Congenital and Structural Heart Disease, performed a closure of an atrial septal defect and patent ductus arteriosus closure. Dr. Hijazi is the course director and a founding member of PICS-AICS.
On July 22, Robert N. Vincent, M.D., co-medical director of the Heart Transplant Program and Director of the Cardiac Catheterization Lab at Children’s Sibley Heart Center will perform two live procedures. The first will be a pulmonary artery angioplasty and the second will be an atrial septal defect closure.
The design of the Infinix CF-i/BP system will assist with the hybrid approach, enhancing collaboration between clinicians and critical equipment to aid diagnosis and treatment.
“We have been using two Toshiba labs for just about a year now. They have been dependable and provide excellent image quality,” said Dr. Vincent. “The thing I like best about them is the five axis system that allows us to move both AP and lateral detectors away from the head of the table giving better access for anesthesia, echo and procedures being performed from the neck or upper chest area.”
The Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS) covers the burgeoning field of interventional therapies for pediatric and adult patients with congenital and structural heart disease. The symposium, held in Las Vegas, Nev., features distinguished faculty lectures, interactive discussions, workshops, live case demonstrations from 12 cardiac centers from around the world, and breakout sessions, covering topics such as devices, implantable valves, bioabsorbable technology, stents, balloons and many new aspects of interventional cardiology.
For more information: www.medical.toshiba.com, www.rush.edu
October 23, 2024 
